{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:32:25Z","timestamp":1790188345739,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.atherosclerosis.2007.11.034","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T11:31:41Z","timestamp":1200483101000},"page":"487-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["CXCL16\/SR-PSOX\u2014A friend or a foe in atherosclerosis?"],"prefix":"10.1016","volume":"197","author":[{"given":"Yuri","family":"Sheikine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Sirsj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/138945006775270240","article-title":"Chemokines as potential therapeutic targets in atherosclerosis","volume":"7","author":"Sheikine","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1189\/jlb.1206761","article-title":"Chemokine regulation of atherosclerosis","volume":"82","author":"Barlic","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.mol.0000183943.20277.26","article-title":"Scavenger receptors: friend or foe in atherosclerosis?","volume":"16","author":"van Berkel","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib5","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"Moore","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib6","doi-asserted-by":"crossref","first-page":"40663","DOI":"10.1074\/jbc.C000761200","article-title":"Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages","volume":"275","author":"Shimaoka","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib8","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.166.8.5145","article-title":"Expression cloning of the STRL33\/BONZO\/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines","volume":"166","author":"Wilbanks","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.171.4.1647","article-title":"Cutting edge: SR-PSOX\/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain","volume":"171","author":"Shimaoka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1189\/jlb.1003465","article-title":"Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells","volume":"75","author":"Shimaoka","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib11","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.4049\/jimmunol.172.10.6362","article-title":"The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10","volume":"172","author":"Abel","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib12","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.172.6.3678","article-title":"A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16","volume":"172","author":"Gough","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2007.04.100","article-title":"Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases","volume":"358","author":"Schulte","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib14","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.4049\/jimmunol.178.12.8064","article-title":"Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes","volume":"178","author":"Hundhausen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile \u2018special agents\u2019 in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/hq1001.096652","article-title":"Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions","volume":"21","author":"Minami","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1204733","article-title":"Distribution and kinetics of SR-PSOX\/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells","volume":"77","author":"Tabata","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.ATV.0000012402.85056.45","article-title":"Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells","volume":"22","author":"Hofnagel","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bbrc.2004.10.160","article-title":"The chemokine and scavenger receptor CXCL16\/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon-gamma","volume":"325","author":"Wagsater","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.ATV.0000043906.61088.4B","article-title":"Expression of CXCL16 in human T cells","volume":"23","author":"Shashkin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V96.1.41.013k53_41_49","article-title":"Expression and coreceptor activity of STRL33\/Bonzo on primary peripheral blood lymphocytes","volume":"96","author":"Sharron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI11902","article-title":"Bonzo\/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential","volume":"107","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.174.1.277","article-title":"Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver","volume":"174","author":"Sato","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib25","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M311660200","article-title":"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell\u2013cell adhesion and aortic smooth muscle cell proliferation","volume":"279","author":"Chandrasekar","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/08892220050075318","article-title":"The immunodeficiency virus coreceptor, Bonzo\/STRL33\/TYMSTR, is expressed by macaque and human skin- and blood-derived dendritic cells","volume":"16","author":"Ignatius","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib27","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","article-title":"Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues","volume":"170","author":"Nakayama","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/CIRCULATIONAHA.106.678474","article-title":"CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall","volume":"116","author":"Galkina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2001-12-0196","article-title":"Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20011712","article-title":"CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection","volume":"195","author":"Motsinger","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib31","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4049\/jimmunol.171.5.2571","article-title":"CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells","volume":"171","author":"Thomas","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib32","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.4049\/jimmunol.171.6.2960","article-title":"Differential chemokine responses and homing patterns of murine TCRalphabeta NKT cell subsets","volume":"171","author":"Johnston","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/intimm\/dxh369","article-title":"A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion","volume":"18","author":"Hara","year":"2006","journal-title":"Int Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.176.1.43","article-title":"The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT","volume":"176","author":"Hase","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.21004","article-title":"Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints","volume":"52","author":"van der Voort","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-8278(02)00328-8","article-title":"Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes","volume":"38","author":"Boisvert","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","article-title":"CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver","volume":"174","author":"Heydtmann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"Wuttge","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.ATV.0000153516.02782.65","article-title":"IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells","volume":"25","author":"Tenger","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib42","doi-asserted-by":"crossref","first-page":"26263","DOI":"10.1074\/jbc.M502586200","volume":"280","author":"Chandrasekar","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib43","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib44","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib45","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1172\/JCI24061","article-title":"Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice","volume":"115","author":"Moore","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/5013","article-title":"Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats","volume":"21","author":"Aitman","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11883-000-0042-z","article-title":"Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes","volume":"2","author":"Gotoda","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(00)04138-6","article-title":"CD36 deficiency associated with insulin resistance","volume":"357","author":"Miyaoka","year":"2001","journal-title":"Lancet"},{"issue":"Suppl. B","key":"10.1016\/j.atherosclerosis.2007.11.034_bib49","first-page":"24B","article-title":"Leukocyte recruitment to atherosclerotic lesions","volume":"20","author":"Cybulsky","year":"2004","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20040086","article-title":"Role of apoptosis in atherosclerosis and its therapeutic implications","volume":"107","author":"Stoneman","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib51","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","article-title":"T cells in atherogenesis: for better or for worse?","volume":"26","author":"Robertson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.ATV.0000114565.42679.c6","article-title":"Upregulation of SR-PSOX\/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease","volume":"24","author":"Yamauchi","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib53","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2174\/1381612043384402","article-title":"Phosphoinositide 3-kinases as targets for therapeutic intervention","volume":"10","author":"Wetzker","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib54","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbrc.2005.03.200","article-title":"CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells","volume":"331","author":"Zhuge","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2796.2005.01469.x","article-title":"Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16\/SR-PSOX gene","volume":"257","author":"Lundberg","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2005.11.025","article-title":"Decreased plasma CXCL16\/SR-PSOX concentration is associated with coronary artery disease","volume":"188","author":"Sheikine","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1567-5688(06)80314-4","article-title":"Serum soluble SR-PSOX\/CXCL16 is an independent biomarker for acute coronary syndrome","volume":"7","author":"Mitsuoka","year":"2006","journal-title":"Atheroscler Suppl."},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2006.09.034","article-title":"CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans","volume":"49","author":"Lehrke","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib59","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2007.01.161","article-title":"Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis","volume":"355","author":"van Lieshout","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.066084","article-title":"Circulating levels of the chemokine CCL18, but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis","author":"van Lieshout","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib61","doi-asserted-by":"crossref","first-page":"26807","DOI":"10.1074\/jbc.C400163200","article-title":"Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain","volume":"279","author":"Shimaoka","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.034_bib62","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.21301","article-title":"Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis","volume":"52","author":"Nanki","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007007563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007007563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:31:21Z","timestamp":1758155481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007007563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0021915007007563"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.11.034","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL16\/SR-PSOX\u2014A friend or a foe in atherosclerosis?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}